baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Wuxi Biologics (Cayman) Inc/ US98260N1081 /

6/14/2024 9:59:29 PM	Chg. -0.1400	Volume	Bid-	Ask-	High	Low
2.9400USD	-4.55%	53,241 Turnover: 154,485.4688	-Bid Size: -	-Ask Size: -	2.9400	2.9300

GlobeNewswire 11/21/2023 Myricx Bio Enters into an Exclusive Antibody License Agreement with WuXi Biologics

GlobeNewswire 10/31/2023 Immutep Quarterly Activities Report Q1 FY24

GlobeNewswire 9/21/2023 Commercial Manufacturing of Eftilagimod Alpha at 2000L Scale Granted Authorization for Clinical Tria...

TeleTrader 10/7/2022 US Commerce Dept adds 31 Chinese firms to 'unverified list'

GlobeNewswire 3/23/2021 AC Immune Reports Full-Year 2020 Financial Results and Provides 2021 R&D Outlook

GlobeNewswire 3/23/2021 Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Deve...

GlobeNewswire 1/22/2021 Immutep Quarterly Activities Report

GlobeNewswire 1/19/2021 Oxford BioTherapeutics Designates Second Bispecific Antibody Program Leveraging WuXi Biologics’ WuXi...

GlobeNewswire 12/16/2020 Immutep Upscales Efti Manufacturing

GlobeNewswire 11/13/2020 AC Immune Reports Q3 2020 Financial Results and Provides Business Update

GlobeNewswire 11/9/2020 AC Immune and WuXi Biologics Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 ...

GlobeNewswire 10/29/2020 AB2 Bio and WuXi Biologics Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Ta...

GlobeNewswire 8/11/2020 Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results

GlobeNewswire 5/29/2020 Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential CO...

GlobeNewswire 5/12/2020 Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results

GlobeNewswire 5/7/2020 Amicus Therapeutics Announces First Quarter 2020 Financial Results and Corporate Updates

GlobeNewswire 5/6/2020 Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates

GlobeNewswire 4/30/2020 Aravive and WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific An...

GlobeNewswire 3/26/2020 Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial ...

GlobeNewswire 3/25/2020 Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19

GlobeNewswire 3/2/2020 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates

GlobeNewswire 2/25/2020 Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to ...

GlobeNewswire 1/13/2020 Amicus Therapeutics Provides Full-Year 2020 Strategic Outlook and Financial Guidance

GlobeNewswire 1/7/2020 Amicus Therapeutics Provides Updates on Clinical, Regulatory and Manufacturing Advancements for AT-G...

GlobeNewswire 10/28/2019 Operational Update

Wuxi Biologics (Cayman) Inc/ US98260N1081 /

If you wish to receive reply to your feedback, please provide your email address.